Article Information
History
- November 22, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Lily E Cohen, MPhil1,2,3,*,
- Chelsea Hansen, MPH4,
- Melissa K Andrew, MD5,
- Shelly A McNeil, MD5,
- Philippe Vanhems, MD6,
- Jan Kyncl, MD7,
- Javier Díez Domingo, MD8,
- Tao Zhang, PhD9,
- Ghassan Dbaibo, MD10,
- Victor Alberto Laguna-Torres, MD11,
- Anca Draganescu, MD12,
- Elsa Baumeister, PhD13,
- Doris Gomez, PhD14,
- Sonia M Raboni, MD15,
- Heloisa I G Giamberardino, MD15,
- Marta C Nunes, PhD16,
- Elena Burtseva, MD17,
- Anna Sominina, MD18,
- Snežana Medić, MD19,
- Daouda Coulibaly, MD20,
- Afif Ben Salah, MD21,
- Nancy A Otieno, PhD22,
- Parvaiz A Koul, MD23,
- Serhat Unal, MD24,
- Mine Durusu Tanriover, MD25,
- Marie Mazur, PharmD1,
- Joseph Bresee, MD2,
- Cecile Viboud, PhD4 and
- Sandra S Chaves, MD26
- 1Ready2Respond, Atlanta, Georgia, USA
- 2The Task Force for Global Health, Atlanta, Georgia, USA
- 3Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 4Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA
- 5Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health, Dalhousie University, Halifax, Nova Scotia, Canada
- 6Hôpital Edouard Herriot, Lyon, France
- 7Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic
- 8Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain
- 9School of Public Health, Fudan University, Shanghai, China
- 10Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon
- 11Clínica Internacional, Instituto de Medicina Tropical Universidad Nacional Mayor de San Marcos, Lima, Peru
- 12National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania
- 13Respiratory Virus Laboratory, Virology Department, INEI-ANLIS, Buenos Aires, Argentina
- 14Grupo de Investigación UNIMOL, Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia
- 15Virology Laboratory, Infectious Diseases Division, Universidade Federal do Paraná; Hospital Pequeno Principe, Curitiba, Paraná, Brazil
- 16South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, and Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 17Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of Russian Federation, Moscow, Russia
- 18Smorodintsev Research Institute of Influenza, St Petersburg, Russia
- 19Institute of Public Health of Vojvodina, Novi Sad; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- 20National Institute of Public Hygiene (INHP), Abidjan, Côte d’Ivoire
- 21Institut Pasteur de Tunis, Tunisia And Arabian Gulf University, Bahrain
- 22Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
- 23Sheri Kashmir Institute of Medical Sciences, Srinagar, India
- 24Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Turkey; and Turkish Society of Internal Medicine, Turkey
- 25Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey; and Turkish Society of Internal Medicine, Turkey
- 26Foundation for Influenza Epidemiology, Fondation de France, Paris, France
- ↵*Corresponding author: Lily Cohen, lily.cohen{at}icahn.mssm.edu, 1-917-455-4366